211 results on '"Baek, Han Joo"'
Search Results
2. Literature review of non-pharmacological treatment for patients with axial spondyloarthritis
3. Particulate matter (PM10) as a newly identified environmental risk factor for acute gout flares: A time-series study
4. Insights from the COVID-19 pandemic: underscoring the paramount value of patient education and counseling for rheumatic diseases
5. Neurobehcet’s Disease with Extensive Invasion of Cerebral Parenchyma
6. Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic
7. The effect of tube voltage combination on image artefact and radiation dose in dual-source dual-energy CT: comparison between conventional 80/140 kV and 80/150 kV plus tin filter for gout protocol
8. Immunoglobulin G4-related hypertrophic pachymeningitis with an isolated scalp mass mimicking a brain tumor: a case report and literature review
9. Korean treatment recommendations for patients with axial spondyloarthritis
10. LP-033 A study of treatment satisfaction in the patients with rheumatoid arthritis and systemic lupus erythematous
11. LSO-019 Effect of air pollutant exposure on disease activity of systemic lupus erythematous: a prospective longitudinal study from Korea
12. Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial
13. Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
14. Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study
15. Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity
16. Overexpression and Unique Rearrangement of VH2 Transcripts in Immunoglobulin Variable Heavy Chain Genes in Ankylosing Spondylitis Patients
17. Fibromyalgia with chronic rheumatic diseases in South Korea: a comparison of clinical and American College of Rheumatology criteria
18. Isolated Tuberculous Myositis: A Systematic Review and Multicenter Cases
19. Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis
20. The Korean College of Rheumatology: 40 Years of Public Health Influence
21. Assessment on Treatments With Conventional Synthetic Disease-modifying Drugs Before Initiating Biologics in Patients With Rheumatoid Arthritis in Korea: A Population-based Study
22. Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study
23. How Should We Classify Patients Who Have Spondylitis and Psoriasis?
24. Efficacy and safety of PG201 (Layla®) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study
25. Clinical characteristics of non‐radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data
26. POEMS syndrome complicated by extensive arterial thromboses
27. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: A 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial
28. Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus
29. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea
30. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçetʼs disease
31. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: A 1-Week, randomized, double-blind, placebo-controlled trial
32. Spondylitis is the most common pattern of psoriatic arthritis in Korea
33. Utility of Magnetic Resonance Imaging and Positron Emission Tomography in Rheumatic Diseases
34. Outcomes and Risk Factors of Systolic Pulmonary Artery Pressure Progression in Patients with Systemic Rheumatic Diseases: Follow-up Results from a Korean Registry
35. Seasonal Variations and Associated Factors of Gout Attacks: a Prospective Multicenter Study in Korea
36. The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
37. Takayasu’s Arteritis Concurrent with Marfan Syndrome: A Case Report
38. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea.
39. Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
40. AB0887 A SURVEY FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH GOUT IN KOREA
41. Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate
42. 2018 APLAR axial spondyloarthritis treatment recommendations
43. Three Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
44. ABNORMAL DISTRIBUTION OF Fcγ RECEPTOR TYPE IIa POLYMORPHISMS IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
45. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51
46. The effect of tube voltage combination on image artefact and radiation dose in dual-source dual-energy CT: comparison between conventional 80/140 kV and 80/150 kV plus tin filter for gout protocol
47. Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA)
48. Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
49. Mean platelet volume as a marker for differentiating disease flare from infection in Behçet's disease
50. Infliximab for refractory oral ulcers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.